Skip to content
DataLookout
Menu

University of Washington clinical trial pipeline

Get alerts when University of Washington's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22

What changed in the last 30 days

28 trials changed in the last 30 days: 0 stopped, 20 with notable changes, 8 with minor changes only.

  1. Notable: Pembrolizumab and Carboplatin · Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Results posted: Nov 20, 2026 University of WashingtonPhase 2 NCT04387227
  2. Notable: Vaccine (STEMVAC) for Improving Survival · Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden Recruitment opened University of WashingtonPhase 2 NCT07721259
  3. Notable: Lay-Delivered Behavioral Activation in Senior Centers Primary completion date changed from estimate of Sep 30, 2025 to Jun 18, 2026 University of WashingtonNot applicable NCT04621877
  4. Minor: Brentuximab Vedotin With or Without Nivolumab · Relapsed or Refractory CD30+ Lymphoma Study completion moved earlier from Jun 3, 2030 to Aug 16, 2028 University of WashingtonPhase 2 NCT01703949
  5. Notable: Systematic Redesign of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) Primary endpoint(s) modified University of WashingtonNot applicable NCT06941428
  6. Notable: [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression · Metastatic Breast Cancer Primary completion pushed from Dec 31, 2027 to Dec 31, 2028 University of WashingtonPhase 1/2 NCT06502691
  7. Notable: Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular Recovery in SCI Primary completion pushed from Dec 1, 2026 to Dec 1, 2028 University of WashingtonNot applicable NCT06313515
  8. Minor: Lung Transplant READY CF 2: CARING CF Ancillary RCT Enrollment closed, study ongoing University of WashingtonNot applicable NCT06032273
  9. Minor: Lung Transplant READY CF 2: A Multi-site RCT Primary completion date changed from estimate of Mar 30, 2026 to Jun 22, 2026 University of WashingtonNot applicable NCT06030206
  10. Notable: TRIFECTA · Neoadjuvant Intravesical Nadofaragene Firadenovec With Enfortumab Vedotin and Pembrolizumab · Muscle Invasive Bladder Cancer, TRIFECTA Trial Primary endpoint(s) modified University of WashingtonPhase 2 NCT07332351
  11. Minor: ISSP · Integrated Suicide Supports and Safety Planning for Youth Primary and study completion pushed from Nov 1, 2026 to Dec 1, 2026 University of WashingtonNot applicable NCT06701006
  12. Notable: VIBRANT · Virtual Implicit Bias Reduction and Neutralization Training Results posted: Nov 10, 2026 University of WashingtonNot applicable NCT05970991
  13. Notable: Non-contrast DWI for Supplemental Screening Primary completion pushed from Sep 2026 to Jul 2027 University of WashingtonNot specified NCT03607552
  14. Notable: Finasteride and Cutibacterium Recruitment opened University of WashingtonPhase 4 NCT07731802
  15. Notable: Resource Allocation for Alcohol Start date changed from estimate of Mar 2025 to Aug 1, 2025 University of WashingtonNot applicable NCT06432361
  16. Minor: PaGeR · Parkinson's Genetic Research Study Changed Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting University of WashingtonNot specified NCT01558479
  17. Notable: AMANI · Accelerating Maternal and Newborn Survival: The AMANI Study Enrolling by invitation only University of WashingtonNot applicable NCT07560839
  18. Notable: VOCALE LBD · Online Peer Support for Caregivers · Lewy Body Dementia Recruitment opened University of WashingtonNot applicable NCT07637097
  19. Notable: E-Socket, Diagnostic Monitoring Primary completion pushed from Jun 30, 2029 to Jun 30, 2032 University of WashingtonNot applicable NCT06432335
  20. Notable: HARNESS · Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke Primary and study completion dates pushed to Dec 31, 2027 University of WashingtonNot applicable NCT05591196
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-19 NCT07949760 WOKVAC Vaccine to Prevent Brain Metastases in Metastatic HER2 Positive Breast Cancer… Phase 2 Not Yet Recruiting
2026-11-12 NCT07930481 Non-invasive Spinal Stimulation for Gait in Genetic Spasticity Enrolling by Invitation
2026-11-04 NCT07915934 Adapting the "Do More, Feel Better" Intervention for Older People Living With HIV Not Yet Recruiting
2026-11-02 NCT07910435 Polatuzumab Vedotin, Mosunetuzumab, and Acalabrutinib for the Treatment of Mantle Cell… Phase 2 Not Yet Recruiting

Active trials by phase

Early Phase 1
4
Phase 1
5
Phase 1/2
7
Phase 2
48
Phase 2/3
2
Phase 3
6
Phase 4
14
Not charted: 183 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 48

Get alerts when University of Washington's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free